000 | 01948 a2200541 4500 | ||
---|---|---|---|
005 | 20250514161454.0 | ||
264 | 0 | _c20040105 | |
008 | 200401s 0 0 eng d | ||
022 | _a0027-8424 | ||
024 | 7 |
_a10.1073/pnas.1835612100 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aSur, Cyrille | |
245 | 0 | 0 |
_aN-desmethylclozapine, an allosteric agonist at muscarinic 1 receptor, potentiates N-methyl-D-aspartate receptor activity. _h[electronic resource] |
260 |
_bProceedings of the National Academy of Sciences of the United States of America _cNov 2003 |
||
300 |
_a13674-9 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAllosteric Site |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aBrain _xmetabolism |
650 | 0 | 4 | _aCell Line |
650 | 0 | 4 |
_aClozapine _xanalogs & derivatives |
650 | 0 | 4 | _aCricetinae |
650 | 0 | 4 |
_aDNA, Complementary _xmetabolism |
650 | 0 | 4 | _aDose-Response Relationship, Drug |
650 | 0 | 4 | _aElectrophysiology |
650 | 0 | 4 |
_aGuanosine 5'-O-(3-Thiotriphosphate) _xmetabolism |
650 | 0 | 4 |
_aHippocampus _xmetabolism |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aInhibitory Concentration 50 |
650 | 0 | 4 | _aMutagenesis, Site-Directed |
650 | 0 | 4 |
_aNeurons _xmetabolism |
650 | 0 | 4 | _aProtein Binding |
650 | 0 | 4 | _aRats |
650 | 0 | 4 |
_aReceptor, Muscarinic M1 _xagonists |
650 | 0 | 4 |
_aReceptors, N-Methyl-D-Aspartate _xmetabolism |
650 | 0 | 4 | _aTime Factors |
700 | 1 | _aMallorga, Pierre J | |
700 | 1 | _aWittmann, Marion | |
700 | 1 | _aJacobson, Marlene A | |
700 | 1 | _aPascarella, Danette | |
700 | 1 | _aWilliams, Jacinta B | |
700 | 1 | _aBrandish, Philip E | |
700 | 1 | _aPettibone, Douglas J | |
700 | 1 | _aScolnick, Edward M | |
700 | 1 | _aConn, P Jeffrey | |
773 | 0 |
_tProceedings of the National Academy of Sciences of the United States of America _gvol. 100 _gno. 23 _gp. 13674-9 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1073/pnas.1835612100 _zAvailable from publisher's website |
999 |
_c14333127 _d14333127 |